Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Laryngeal Diseases

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Laryngeal Diseases in 1 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Laryngeal Diseases: Pathological processes involving any part of the LARYNX which coordinates many functions such as voice production, breathing, swallowing, and coughing.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sauvageau, A1

Other Studies

1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Laryngeal Diseases

ArticleYear
Death from a possible anaphylactic reaction to ecstasy.
    Clinical toxicology (Philadelphia, Pa.), 2008, Volume: 46, Issue:2

    Topics: Adolescent; Anaphylaxis; Autopsy; Brain Edema; Emergency Service, Hospital; Fatal Outcome; Female; H

2008